News - Stivarga, Xarelto

Filter

Current filters:

StivargaXarelto

Popular Filters

Bayer initiates Ph III trail of Xarelto in cardiac event prevention; R&D day presentation

14-11-2012

German drug major Bayer (BAYN: DE) has initiated the Phase III COMPASS study of its oral anticoagulant…

AlpharadinBayerCardio-vascularOncologyOphthalmicsPharmaceuticalResearchStivargaXarelto

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top